Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
BMC Infectious Diseases|February 23, 2019
Use of Ceftaroline Fosamil in Osteomyelitis: CAPTURE Study ExperienceLeonard B Johnson, Ananthakrishnan Ramani, David J Guervil
International Journal of Antimicrobial Agents|February 4, 2019
Ceftaroline fosamil for the treatment of Gram-positive endocarditis: CAPTURE study experienceChristopher J Destache, David J Guervil, Keith S Kaye
Diagnostic Microbiology and Infectious Disease|May 31, 2015
Lower antibiotic costs attributable to clinical microbiology roundsRichard S P Huang, David J Guervil, Robert L Hunter, et al.
Journal of Pharmacy Practice|December 28, 2017
Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory ConcentrationsJerry Altshuler, David J Guervil, Charles D Ericsson, et al.
Therapeutics and Clinical Risk Management|April 22, 2015
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unitChristy Maggiore, Jose A Vazquez, David J Guervil, et al.
The Annals of Pharmacotherapy|June 30, 2011
Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusionDavid J Guervil, Amy F Rosenberg, Almut G Winterstein, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 29, 2014
Significant publications on infectious diseases pharmacotherapy in 2013Andrew S Hunter, David J Guervil, Katherine K Perez, et al.
International Journal of Antimicrobial Agents|February 11, 2015
Cefepime free minimum concentration to minimum inhibitory concentration (fCmin/MIC) ratio predicts clinical failure in patients with Gram-negative bacterial pneumoniaSamuel L Aitken, Jerry Altshuler, David J Guervil, et al.
Pageof 2